Anticancer Research: 39 (2)

February 2019; Volume 39,Issue 2

Reviews

You have access
MicroRNA-based Targeted Therapeutics in Pancreatic Cancer
NILGUN GURBUZ and BULENT OZPOLAT

Anticancer Research February 2019, 39 (2) 529-532; DOI: https://doi.org/10.21873/anticanres.13144
You have access
The Role of KRAS in Endometrial Cancer: A Mini-Review
MICHAIL SIDERIS, ELIF ILIRIA EMIN, ZIENA ABDULLAH, JOHN HANRAHAN, KONSTANTINA MARIA STEFATOU, VASILEIOS SEVAS, ECE EMIN, TONY HOLLINGWORTH, FUNLAYO ODEJINMI, SAVVAS PAPAGRIGORIADIS, SOTIRIS VIMPLIS and FREDRIC WILLMOTT

Anticancer Research February 2019, 39 (2) 533-539; DOI: https://doi.org/10.21873/anticanres.13145
You have access
Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer
NITHIKOON AKSORN and PITHI CHANVORACHOTE

Anticancer Research February 2019, 39 (2) 541-548; DOI: https://doi.org/10.21873/anticanres.13146

Experimental Studies

You have access
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer
TOSHIYUKI SEKI, JIANYUN LIU, RANDY R. BRUTKIEWICZ and MORIYA TSUJI

Anticancer Research February 2019, 39 (2) 549-555; DOI: https://doi.org/10.21873/anticanres.13147
You have access
High miR-3687 Expression Affects Migratory and Invasive Ability of Oesophageal Carcinoma
KOTARO HAGIO, SHINJI FURUYA, JIRO NAKAMURA, SUGURU MARUYAMA, KENSUKE SHIRAISHI, HIROKI SHIMIZU, HIDENORI AKAIKE, NAOHIRO HOSOMURA, YOSHIHIKO KAWAGUCHI, HIDETAKE AMEMIYA, HIROMICHI KAWAIDA, MAKOTO SUDO, SHINGO INOUE, HIROSHI KONO and DAISUKE ICHIKAWA

Anticancer Research February 2019, 39 (2) 557-565; DOI: https://doi.org/10.21873/anticanres.13148
You have access
Association of CD31 and p53 With Survival of Ovarian Cancer Patients
LENE RASK, CLAUS K. HØGDALL, SUSANNE K. KJAER, LISE CHRISTENSEN, ALLAN JENSEN, JAN BLAAKAER, IB JARLE CHRISTENSEN and ESTRID V.S. HØGDALL

Anticancer Research February 2019, 39 (2) 567-576; DOI: https://doi.org/10.21873/anticanres.13149
You have access
Oligodendrocytes Up-regulate the Invasive Activity of Glioblastoma Cells via the Angiopoietin-2 Signaling Pathway
TOSHIYUKI KAWASHIMA, MASAKAZU YASHIRO, HIROAKI KASASHIMA, YUZO TERAKAWA, TAKEHIRO UDA, KOSUKE NAKAJO, RYOKO UMABA, YUTA TANOUE, SAMANTHA TAMRAKAR and KENJI OHATA

Anticancer Research February 2019, 39 (2) 577-584; DOI: https://doi.org/10.21873/anticanres.13150
You have access
Cytoplasmic Keap1 Expression Is Associated With Poor Prognosis in Endometrial Cancer
ANNE M. AHTIKOSKI, JUHA KANGAS, RIIKKA SALONEN, ULLA PUISTOLA and PEETER KARIHTALA

Anticancer Research February 2019, 39 (2) 585-590; DOI: https://doi.org/10.21873/anticanres.13151
You have access
Isothiocyanate-induced Cell Cycle Arrest in a Novel In Vitro Exposure Protocol of Human Malignant Melanoma (A375) Cells
THEODORA MANTSO, IOANNIS ANESTOPOULOS, ELEFTHERIA LAMPRIANIDOU, IOANNIS KOTSIANIDIS, AGLAIA PAPPA and MIHALIS I. PANAYIOTIDIS

Anticancer Research February 2019, 39 (2) 591-596; DOI: https://doi.org/10.21873/anticanres.13152
You have access
Basic Gene Expression Characteristics of Glioma Stem Cells and Human Glioblastoma
DAISUKE SAKAMOTO, TOSHINORI TAKAGI, MITSUGU FUJITA, SEIICHI OMURA, YASUNORI YOSHIDA, TOMOKO IIDA and SHINICHI YOSHIMURA

Anticancer Research February 2019, 39 (2) 597-607; DOI: https://doi.org/10.21873/anticanres.13153
You have access
AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1
MASAHIRO YAMAMOTO, SHUHEI SUZUKI, KEITA TOGASHI, TOMOMI SANOMACHI, SHIZUKA SEINO, CHIFUMI KITANAKA and MASASHI OKADA

Anticancer Research February 2019, 39 (2) 609-617; DOI: https://doi.org/10.21873/anticanres.13154
You have access
Para-aortic Lymph Node Invasion in High-risk Endometrial Cancer: Performance of ¹⁸FDG PET-CT
MAXIME LEGROS, FRANÇOIS MARGUERITTE, ANTOINE TARDIEU, ELISE DELUCHE, VALERE BELLE MBOU, AYMELINE LACORRE, ALEXANDRU CEUCA, YVES AUBARD, JACQUES MONTEIL, CAMILLE SALLEE and TRISTAN GAUTHIER

Anticancer Research February 2019, 39 (2) 619-625; DOI: https://doi.org/10.21873/anticanres.13155
You have access
Tenascin XB Is a Novel Diagnostic Marker for Malignant Mesothelioma
KOJI NAKAYAMA, MASAHIRO SEIKE, RINTARO NORO, SUSUMU TAKEUCHI, KUNIKO MATSUDA, SHINOBU KUNUGI, KAORU KUBOTA and AKIHIKO GEMMA

Anticancer Research February 2019, 39 (2) 627-633; DOI: https://doi.org/10.21873/anticanres.13156
You have access
Tumorous CD10 Is More Strongly Related to the Progression of Urothelial Carcinoma than Stromal CD10
ARISA KUMAGAI-TOGASHI, HIROSHI UOZAKI, YOSHINAO KIKUCHI, SHIORI WATABE, SATOE NUMAKURA and MASATO WATANABE

Anticancer Research February 2019, 39 (2) 635-640; DOI: https://doi.org/10.21873/anticanres.13157
You have access
Survival Probabilities Related to Histology, Grade and Stage in Patients With Salivary Gland Tumors
YAIR ISRAEL, ADI RACHMIEL, KONSTANTIN GOUREVICH and RAFAEL NAGLER

Anticancer Research February 2019, 39 (2) 641-647; DOI: https://doi.org/10.21873/anticanres.13158
You have access
Chloroquine Enhances Rapamycin-induced Apoptosis in MG63 Cells
YOICHI ISHIBASHI, OSAMU NAKAMURA, YOSHIKI YAMAGAMI, HIDEKI NISHIMURA, NATSUKO FUKUOKA and TETSUJI YAMAMOTO

Anticancer Research February 2019, 39 (2) 649-654; DOI: https://doi.org/10.21873/anticanres.13159
You have access
Class III β-tubulin Expression in Colorectal Neoplasms Is a Potential Predictive Biomarker for Paclitaxel Response
SIDIKA ÖZTOP, AYNUR IŞIK, GÜNEŞ GÜNER, HAKAN GÜRDAL, ERDEM KARABULUT, ERKAN YILMAZ and AYTEKİN AKYOL

Anticancer Research February 2019, 39 (2) 655-662; DOI: https://doi.org/10.21873/anticanres.13160
You have access
Increased Sphingosine Kinase 1 Expression Predicts Distant Metastasis and Poor Outcome in Patients With Colorectal Cancer
GO EUN BAE, SUNG-IM DO, KYUNGEUN KIM, JI HYUN PARK, SIHYUN CHO and HYUN-SOO KIM

Anticancer Research February 2019, 39 (2) 663-670; DOI: https://doi.org/10.21873/anticanres.13161
You have access
Identification of Genomic Alterations Acquired During Treatment With EGFR-TKIs in Non-small Cell Lung Cancer
NAOKI KUBO, TAISHI HARADA, YOSHIMASA SHIRAISHI, KANAME NOSAKI, NORIAKI NAKAGAKI, MASAFUMI TAKESHITA, HIROSHI OUCHI, EIJI IWAMA, KENTARO TANAKA, ISAMU OKAMOTO, HIROYUKI SASAKI and YOICHI NAKANISHI

Anticancer Research February 2019, 39 (2) 671-677; DOI: https://doi.org/10.21873/anticanres.13162
You have access
Emodin Induces Death in Human Cervical Cancer Cells Through Mitotic Catastrophe
WOJCIECH TRYBUS, TEODORA KRÓL, EWA TRYBUS, ANNA STACHURSKA, GRZEGORZ KRÓL and ANNA KOPACZ-BEDNARSKA

Anticancer Research February 2019, 39 (2) 679-686; DOI: https://doi.org/10.21873/anticanres.13163
You have access
Apoptosis Induced by Ultraviolet A Exposure in the Presence of Enoxacin in HL-60 Cells
HARUKA SHINADA, TAKAHIRO WATANABE, KAZUHO OKUDAIRA, YUMIKO IWASE, KOJI NISHI and NAGAHIKO YUMITA

Anticancer Research February 2019, 39 (2) 687-693; DOI: https://doi.org/10.21873/anticanres.13164
You have access
Chrysin-induced ERK1/2 Phosphorylation Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib
CHING-TING WEI, LEI-CHIN CHEN, YI-PING HSIANG, YUNG-JUN HUNG, PEI-HSUAN CHIEN, HSIAO-LIN PAN and YUN-JU CHEN

Anticancer Research February 2019, 39 (2) 695-701; DOI: https://doi.org/10.21873/anticanres.13165
You have access
Low Expression of Toll-like Receptor 4 Is Associated With Poor Prognosis in Bladder Cancer
YOSHITO KUSUHARA, KEI DAIZUMOTO, KAICHI KAWAI, KENTO HIRAYAMA, MINORU KOWADA, TERUMICHI SHINTANI, YAYOI FUKUHARA, TSOGT-OCHIR DONDOO, KEISUKE OZAKI, MEGUMI TSUDA, TOMOYA FUKAWA, HIROYOSHI NAKATSUJI, YOSHIMI BANDO, HISANORI UEHARA, TOMOHARU FUKUMORI, MASAYUKI TAKAHASHI and HIRO-OMI KANAYAMA

Anticancer Research February 2019, 39 (2) 703-711; DOI: https://doi.org/10.21873/anticanres.13166
You have access
CDK4/6 Inhibitor LEE011 Is a Potential Radiation-sensitizer in Head and Neck Squamous Cell Carcinoma: An In Vitro Study
TZONG-SHYUAN TAI, PAI-MEI LIN, CHING-FANG WU, SHIH-KAI HUNG, CHUNG-I HUANG, CHIH-CHUN WANG and YU-CHIEH SU

Anticancer Research February 2019, 39 (2) 713-720; DOI: https://doi.org/10.21873/anticanres.13167
You have access
The C-Terminus of Hepatitis B Virus-encoded X Protein Is Required for Lapatinib Sensitivity in Hepatocellular Carcinoma Cells
JHEN-YU CHEN, WEI-CHIEN HUANG, CHING-TING WEI, PEI-HSUAN CHIEN and YUN-JU CHEN

Anticancer Research February 2019, 39 (2) 721-726; DOI: https://doi.org/10.21873/anticanres.13168
You have access
Simvastatin Strongly Augments Proapoptotic, Anti-inflammatory and Cytotoxic Activity of Oxicam Derivatives in Doxorubicin-resistant Colon Cancer Cells
KAMILA ŚRODA-POMIANEK, KRYSTYNA MICHALAK, ANNA PALKO-ŁABUZ, ANNA URYGA, BERENIKA SZCZĘŚNIAK-SIĘGA and OLGA WESOŁOWSKA

Anticancer Research February 2019, 39 (2) 727-734; DOI: https://doi.org/10.21873/anticanres.13169
You have access
Antiangiogenic Human Monoclonal Antibody Ramucirumab Radiolabelling: In Vitro Evaluation on VEGFR2-positive Cell Lines
JIRI JANOUSEK, PAVEL BARTA, ZBYNEK NOVY, KATERINA ZILKOVA and FRANTISEK TREJTNAR

Anticancer Research February 2019, 39 (2) 735-744; DOI: https://doi.org/10.21873/anticanres.13170
You have access
Curcumin and Cinnamaldehyde as PTP1B Inhibitors With Antidiabetic and Anticancer Potential
TOMASZ KOSTRZEWA, PAULINA PRZYCHODZEN, MAGDALENA GORSKA-PONIKOWSKA and ALICJA KUBAN-JANKOWSKA

Anticancer Research February 2019, 39 (2) 745-749; DOI: https://doi.org/10.21873/anticanres.13171
You have access
Effect of High-dose Vitamin C Combined With Anti-cancer Treatment on Breast Cancer Cells
SOO JUNG LEE, JAE-HWAN JEONG, IN HEE LEE, JEEYEON LEE, JIN HYANG JUNG, HO YONG PARK, DUK HEE LEE and YEE SOO CHAE

Anticancer Research February 2019, 39 (2) 751-758; DOI: https://doi.org/10.21873/anticanres.13172
You have access
Radiosensitization of Glioblastoma Cells by a Novel DNA Methyltransferase-inhibiting Phthalimido-Alkanamide Derivative
CHAN WOO WEE, JIN HO KIM, HAK JAE KIM, HYUN-CHEOL KANG, SOO YOUN SUH, BEOM SOO SHIN, EUNSOOK MA and IL HAN KIM

Anticancer Research February 2019, 39 (2) 759-769; DOI: https://doi.org/10.21873/anticanres.13173
You have access
Effect of Radiation on the Expression of CVD-related miRNAs, Inflammation and Endothelial Dysfunction of HUVECs
ROSER ESPLUGAS, MONTSERRAT BELLÉS, NOEMÍ SERRA, MERITXELL ARENAS, VÍCTOR HERNÁNDEZ, JOAN CARLES VALLVÉ and VICTORIA LINARES

Anticancer Research February 2019, 39 (2) 771-780; DOI: https://doi.org/10.21873/anticanres.13174

Clinical Studies

You have access
Cancer Site and Adverse Events Induced by Immune Checkpoint Inhibitors: A Retrospective Analysis of Real-life Experience at a Single Institution
AMMAR SUKARI, MISAKO NAGASAKA, ROBA ALHASAN, DHAVAL PATEL, ANTOINETTE WOZNIAK, RADHAKRISHNAN RAMCHANDREN, ULKA VAISHAMPAYAN, AMY WEISE, LAWRENCE FLAHERTY, HYEJEONG JANG, SEONGHO KIM and SHIRISH GADGEEL

Anticancer Research February 2019, 39 (2) 781-790; DOI: https://doi.org/10.21873/anticanres.13175
You have access
No Evidence for Increased Brain Tumour Incidence in the Swedish National Cancer Register Between Years 1980-2012
JONAS NILSSON, JACOB JÄRÅS, ROGER HENRIKSSON, GEORG HOLGERSSON, STEFAN BERGSTRÖM, JIMMY ESTENBERG, TORSTEN AUGUSTSSON and MICHAEL BERGQVIST

Anticancer Research February 2019, 39 (2) 791-796; DOI: https://doi.org/10.21873/anticanres.13176
You have access
Autoimmunity and Benefit from Trastuzumab Treatment in Breast Cancer: Results from the HERA Trial
AMIR SONNENBLICK, ANDREW BAILEY, BEATRICE UZIELY, MICHAEL UNTCH, IAN SMITH, LUCA GIANNI, JOSE BASELGA, CHRISTIAN JACKISCH, DAVID CAMERON, RICHARD BELL, DIMITRIOS ZARDAVAS, NEDAL AL-SAKAFF, RICHARD D. GELBER, MITCH DOWSETT, BRIAN LEYLAND-JONES, MARTINE J. PICCART-GEBHART and EVANDRO DE AZAMBUJA

Anticancer Research February 2019, 39 (2) 797-802; DOI: https://doi.org/10.21873/anticanres.13177
You have access
Patterns of Care in Pediatric Craniopharyngioma: Outcomes Following Definitive Radiotherapy
TANNER K. HILL, MICHAEL J. BAINE, VIVEK VERMA, MORSHED ALAM, ELIZABETH R. LYDEN, CHI LIN, EILEEN P. CONNOLLY and CHI ZHANG

Anticancer Research February 2019, 39 (2) 803-807; DOI: https://doi.org/10.21873/anticanres.13178
You have access
Nitrotyrosine (NT), a Nitrosative Stress Biomarker, Plasma Concentrations in Gallstone Disease and Cancer Patients
IINA SAIMANEN, DINA RAHKOLA, VIIVI KUOSMANEN, JARI KÄRKKÄINEN, TUOMAS SELANDER, ANU HOLOPAINEN, SAMULI ASPINEN and MATTI ESKELINEN

Anticancer Research February 2019, 39 (2) 809-814; DOI: https://doi.org/10.21873/anticanres.13179
You have access
Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer
MASAHIRO KATSURADA, TATSUYA NAGANO, MOTOKO TACHIHARA, TATSUNORI KIRIU, KOICHI FURUKAWA, KIYOKO KOYAMA, TAKEHIRO OTOSHI, REINA SEKIYA, DAISUKE HAZAMA, DAISUKE TAMURA, KYOSUKE NAKATA, NAOKO KATSURADA, MASATSUGU YAMAMOTO, KAZUYUKI KOBAYASHI and YOSHIHIRO NISHIMURA

Anticancer Research February 2019, 39 (2) 815-825; DOI: https://doi.org/10.21873/anticanres.13180
You have access
Manifestations and Treatment of Adult-onset Symptomatic Optic Pathway Glioma in Neurofibromatosis Type 1
JULIANE MEHLAN, FRANK SCHÜTTAUF, JOHANNES M. SALAMON, UWE KORDES, REINHARD E. FRIEDRICH and VICTOR-FELIX MAUTNER

Anticancer Research February 2019, 39 (2) 827-831; DOI: https://doi.org/10.21873/anticanres.13181
You have access
Crypts With Corrupted Shapes in Non-polypoid Adenomas
CARLOS A. RUBIO and PETER T. SCHMIDT

Anticancer Research February 2019, 39 (2) 833-838; DOI: https://doi.org/10.21873/anticanres.13182
You have access
Malignant Peritoneal Mesothelioma: Treatment Options and Survival
SILJA A.S. SALO, ILKKA ILONEN, SANNA LAAKSONEN, MARJUKKA MYLLÄRNIEMI, JARMO A. SALO and TUOMO RANTANEN

Anticancer Research February 2019, 39 (2) 839-845; DOI: https://doi.org/10.21873/anticanres.13183
You have access
Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature
MARIA A. SMOLLE, KARL KASHOFER, JAKOB M. RIEDL, MICHAEL STOTZ and ARMIN GERGER

Anticancer Research February 2019, 39 (2) 847-852; DOI: https://doi.org/10.21873/anticanres.13184
You have access
The Effect of Supplementary Omegaven® on the Clinical Outcome of Patients With Advanced Esophagogastric Adenocarcinoma Receiving Palliative Epirubicin, Oxaliplatin, and Capecitabine Chemotherapy: A Phase II clinical trial
AMAR M. ELTWERI, ANNE L. THOMAS, WEN Y. CHUNG, BRUNO MORGAN, JOHN THOMPSON, ASHLEY R. DENNISON and DAVID J. BOWREY

Anticancer Research February 2019, 39 (2) 853-861; DOI: https://doi.org/10.21873/anticanres.13185
You have access
Age Adjusted Charlson Comorbidity Index Strongly Influences Survival, Irrespective of Performance Status and Age, in Patients With Advanced Prostatic Cancer Treated With Enzalutamide
HENDRIK KAREL VAN HALTEREN and GERARD VREUGDENHIL

Anticancer Research February 2019, 39 (2) 863-866; DOI: https://doi.org/10.21873/anticanres.13186
You have access
Validation and Verification of Three-dimensional Systems in Laparoscopic Distal Pancreatectomy
EUNSUNG JUN, ABDULWAHAB A. ALSHAHRANI, KI BYUNG SONG, DAE WOOK HWANG, JAE HOON LEE, SANG HYUN SHIN, YOUNG-JOO LEE and SONG CHEOL KIM

Anticancer Research February 2019, 39 (2) 867-874; DOI: https://doi.org/10.21873/anticanres.13187
You have access
Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study
WOLFGANG SCHULTZE-SEEMANN, HOLGER SCHULZ, BARBARA TSCHECHNE and MANUEL HÄCKL

Anticancer Research February 2019, 39 (2) 875-882; DOI: https://doi.org/10.21873/anticanres.13188
You have access
Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein
TAKANOBU YAMAO, YO-ICHI YAMASHITA, KATSUNORI IMAI, NAOKI UMEZAKI, MASAYO TSUKAMOTO, YUKI KITANO, KOTA ARIMA, TATSUNORI MIYATA, SHIGEKI NAKAGAWA, HIROHISA OKABE, HIROMITSU HAYASHI, AKIRA CHIKAMOTO, TAKATOSHI ISHIKO and HIDEO BABA

Anticancer Research February 2019, 39 (2) 883-889; DOI: https://doi.org/10.21873/anticanres.13189
You have access
Radiation Therapy for Extrapelvic Lymph Node Recurrence After Curative Treatment for Cervical Cancer
TAKASHI UNO, AKI KANAZAWA, MIHO WATANABE NEMOTO, RINTARO HARADA, HIROKI KOBAYASHI, MAKOTO SAITO, YUMA IWAI, HIROKAZU USUI, AKIRA MITSUHASHI and MAKIO SHOZU

Anticancer Research February 2019, 39 (2) 891-895; DOI: https://doi.org/10.21873/anticanres.13190
You have access
Neoadjuvant Tyrosine Kinase Inhibition in Locally-advanced Non-small Cell Lung Cancer: Two Cases and a Brief Literature Review
ANISH B. PARIKH, LINDSAY HAMMONS and JORGE E. GOMEZ

Anticancer Research February 2019, 39 (2) 897-902; DOI: https://doi.org/10.21873/anticanres.13191
You have access
Neuroendocrine Tumor of the Hilar Bile Duct
NAOKI UMEZAKI, DAISUKE HASHIMOTO, YO-ICHI YAMASHITA, SHIGEKI NAKAGAWA, YOUSUKE NAKAO, RUMI ITOYAMA, TOSHIHIKO YUSA, TAKANOBU YAMAO, HIROHISA OKABE, KATSUNORI IMAI, HIROMITSU HAYASHI, AKIRA CHIKAMOTO and HIDEO BABA

Anticancer Research February 2019, 39 (2) 903-907; DOI: https://doi.org/10.21873/anticanres.13192
You have access
Carbon Ion Radiotherapy in the Management of the Tumors of the Peripheral Nervous System
VIVIANA VITOLO, MARIA ROSARIA FIORE, AMELIA BARCELLINI, BARBARA VISCHIONI, ALBERTO IANNALFI, ANGELICA FACOETTI, PIERO FOSSATI, MARIA BONORA, SARA RONCHI, EMMA D'IPPOLITO, RACHELE PETRUCCI, GISELA VISELNER, MARIO CIOCCA, LORENZO PREDA, FRANCESCA VALVO and ROBERTO ORECCHIA

Anticancer Research February 2019, 39 (2) 909-913; DOI: https://doi.org/10.21873/anticanres.13193
You have access
Diagnostic Utility of Third-Look, Contrast-Enhanced Sonography Followed by Needle Biopsy for MRI, But Not Second-look Ultrasonography-detected Breast Lesions
TOMOHIRO MIYAKE, SEUNG JIN KIM, MASAFUMI SHIMODA, NAOFUMI KAGARA, TOMONORI TANEI, YASUTO NAOI, KENZO SHIMAZU and SHINZABURO NOGUCHI

Anticancer Research February 2019, 39 (2) 915-921; DOI: https://doi.org/10.21873/anticanres.13194
You have access
Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain Metastases
KOICHI SARUWATARI, TOKUNORI IKEDA, SHO SAEKI, NAOKI SHINGU, KOSUKE IMAMURA, TAIYOU KOMATU, SUNAO USHIJIMA, HIROTAKA MARUYAMA, KOSUKE KASHIWABARA, YUSUKE TOMITA, HIDENORI ICHIYASU, KAZUHIKO FUJII and TAKURO SAKAGAMI

Anticancer Research February 2019, 39 (2) 923-931; DOI: https://doi.org/10.21873/anticanres.13195
You have access
Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy
HIROFUMI MATSUOKA, KEIICHIRO NAKAMURA, YUKO MATSUBARA, NAOYUKI IDA, TAKESHI NISHIDA, CHIKAKO OGAWA, KUNIAKI KATSI, SUSUMU KANAZAWA and HISASHI MASUYAMA

Anticancer Research February 2019, 39 (2) 933-939; DOI: https://doi.org/10.21873/anticanres.13196
You have access
Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma
AKIRA WATANABE, NORIHUMI HARIMOTO, KENICHIRO ARAKI, NORIO KUBO, TAKAMICHI IGARASHI, MARIKO TSUKAGOSHI, NORIHIRO ISHII, TAKAHIRO YAMANAKA, TOMOHARU YOSHIZUMI and KEN SHIRABE

Anticancer Research February 2019, 39 (2) 941-947; DOI: https://doi.org/10.21873/anticanres.13197
You have access
County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer
MU LI, SOPHI GU, RUI MAO, YING NING, NITIN TRIVEDI, AHMAD SIDDIQUI, PENGYANG LI and LIHONG HUO

Anticancer Research February 2019, 39 (2) 949-956; DOI: https://doi.org/10.21873/anticanres.13198
You have access
Low-molecular-weight Protein Tyrosine Phosphatase Is a Possible Biomarker for Predicting Postoperative Biochemical Recurrence in Prostate Cancer With Negative Surgical Margins
HIROFUMI KUROSE, KOSUKE UEDA, REIICHIRO KONDO, SACHIKO OGASAWARA, HIRONORI KUSANO, SAKIKO SANADA, YOSHIKI NAITO, JUN AKIBA, TATSUYUKI KAKUMA, TSUKASA IGAWA and HIROHISA YANO

Anticancer Research February 2019, 39 (2) 957-964; DOI: https://doi.org/10.21873/anticanres.13199
You have access
Impact of Repeated Hepatectomy on Liver Regeneration in Hepatocellular Carcinoma: A Propensity Score-based Analysis
KOTA ARIMA, HIDETOSHI NITTA, TORU BEPPU, SHIGEKI NAKAGAWA, HIROHISA OKABE, KATSUNORI IMAI, AKIRA CHIKAMOTO, YO-ICHI YAMASHITA, YASUYUKI YAMASHITA and HIDEO BABA

Anticancer Research February 2019, 39 (2) 965-970; DOI: https://doi.org/10.21873/anticanres.13200
You have access
Impact of Metabolic Parameters of ¹⁸F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma
NORIFUMI HARIMOTO, KOUKI HOSHINO, RYO MURANUSHI, KEI HAGIWARA, TAKAHIRO YAMANAKA, NORIHIRO ISHII, MARIKO TSUKAGOSHI, TAKAMICHI IGARASHI, HIROSHI TANAKA, AKIRA WATANABE, NORIO KUBO, KENICHIROU ARAKI, HIROYASU TOMONAGA, TETSUYA HIGUCHI, YOSHITO TSUSHIMA and KEN SHIRABE

Anticancer Research February 2019, 39 (2) 971-977; DOI: https://doi.org/10.21873/anticanres.13201
You have access
Postoperative Pneumonia After Esophagectomy and Systemic Inflammatory Response Syndrome
SHINICHI ASAKA, TAKESHI SHIMAKAWA, KENTARO YAMAGUCHI, TAKAO KATSUBE, TAKEBUMI USUI, HAJIME YOKOMIZO, SHUNICHI SHIOZAWA and YOSHIHIKO NARITAKA

Anticancer Research February 2019, 39 (2) 979-985; DOI: https://doi.org/10.21873/anticanres.13202
You have access
Adverse Effects of Preoperative Sarcopenia on Postoperative Complications of Patients With Gastric Cancer
TATSURO TAMURA, KATSUNOBU SAKURAI, MIKIO NAMBARA, YUICHIRO MIKI, TAKAHIRO TOYOKAWA, NAOSHI KUBO, HIROAKI TANAKA, KAZUYA MUGURUMA, MASAKAZU YASHIRO and MASAICHI OHIRA

Anticancer Research February 2019, 39 (2) 987-992; DOI: https://doi.org/10.21873/anticanres.13203
You have access
Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer
DONGHA LEE, TAKERU MATSUDA, KIMIHIRO YAMASHITA, HIROSHI HASEGAWA, MASASHI YAMAMOTO, SHINGO KANAJI, TARO OSHIKIRI, TETSU NAKAMURA, SATOSHI SUZUKI, TAKUMI FUKUMOTO and YOSHIHIRO KAKEJI

Anticancer Research February 2019, 39 (2) 993-998; DOI: https://doi.org/10.21873/anticanres.13204
You have access
Usefulness of Implementing Comprehensive Pharmaceutical Care for Metastatic Renal Cell Carcinoma Outpatients Treated with Pazopanib
MAKI TODO, SUGURU SHIROTAKE, KOSHIRO NISHIMOTO, YOTA YASUMIZU, GOU KANEKO, HIDEYUKI KONDO, TAKASHI OKABE, HIDEKI MAKABE and MASAFUMI OYAMA

Anticancer Research February 2019, 39 (2) 999-1004; DOI: https://doi.org/10.21873/anticanres.13205
You have access
Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer
SANG HYUN SHIN, YEJONG PARK, DAE WOOK HWANG, KI BYUNG SONG, JAE HOON LEE, JAEWOO KWON, CHANGHOON YOO, SHADI ALSHAMMARY and SONG CHEOL KIM

Anticancer Research February 2019, 39 (2) 1005-1012; DOI: https://doi.org/10.21873/anticanres.13206
You have access
Use of a Reinforced Triple-row Stapler Following Distal Pancreatectomy Reduces the Incidence of Postoperative Pancreatic Fistula in Patients With a High BMI
HIROMICHI KAWAIDA, HIROSHI KONO, HIDETAKE AMEMIYA, NAOHIRO HOSOMURA, RYO SAITO, KAZUNORI TAKAHASHI, ATSUSHI YAMAMOTO, MITSUAKI WATANABE, SHINJI FURUYA, HIROKI SHIMIZU, HIDENORI AKAIKE, YOSHIHIKO KAWAGUCHI, MAKOTO SUDO, MASANORI MATUSDA, JUN ITAKURA, HIDEKI FUJII and DAISUKE ICHIKAWA

Anticancer Research February 2019, 39 (2) 1013-1018; DOI: https://doi.org/10.21873/anticanres.13207
You have access
Gastric Lavage Malignant Cells (yGL) and Hypohemoglobinemia (yAnemia) as New Systems of Tumor Regression Grading and Prognostic Prediction for Gastric Cancer After Neoadjuvant Treatment
EDOARDO VIRGILIO, ENRICO GIARNIERI, MARIA ROSARIA GIOVAGNOLI, MONICA MONTAGNINI, ANTONELLA PROIETTI, ROSARIA D'URSO, ALESSANDRA FEGIZ, PAOLO MERCANTINI, GENOVEFFA BALDUCCI and MARCO CAVALLINI

Anticancer Research February 2019, 39 (2) 1019-1027; DOI: https://doi.org/10.21873/anticanres.13208
You have access
Evaluation of Tolerability of Trifluridine/Tipiracil Combination Tablet in Patients With Advanced/Recurrent Colorectal Cancer
MICHIO KIMURA, EISEKI USAMI, HITOMI TERAMACHI and TOMOAKI YOSHIMURA

Anticancer Research February 2019, 39 (2) 1029-1034; DOI: https://doi.org/10.21873/anticanres.13209
You have access
Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients
DIDIER AUTRAN, MARYLINE BARRIE, MONA MATTA, COLETTE MONSERRAT, CHANTAL CAMPELLO, GREGORIO PETRIRENA, CELINE BOUCARD, LAETITIA PADOVANI, ANDERSON LOUNDOU, ROMAIN APPAY, THOMAS GRAILLON, HENRY DUFOUR, DOMINIQUE FIGARELLA-BRANGER, OLIVIER CHINOT and EMELINE TABOURET

Anticancer Research February 2019, 39 (2) 1035-1041; DOI: https://doi.org/10.21873/anticanres.13210
You have access
Uptake of ¹⁸F-Fluorodeoxyglucose in Major Salivary Gland Cancer Predicts Survival Adjusting for Pathological Stage
HIDENORI SUZUKI, TSUNEO TAMAKI, MASAMI NISHIO, HOSHINO TERADA, DAISUKE NISHIKAWA, YUSUKE KOIDE, SHINTARO BEPPU and NOBUHIRO HANAI

Anticancer Research February 2019, 39 (2) 1043-1049; DOI: https://doi.org/10.21873/anticanres.13211
You have access
Prognostic Significance of the C-Reactive Protein-to-Albumin Ratio in Patients With Metastatic Colorectal Cancer Treated With Trifluridine/Thymidine Phosphorylase Inhibitor as Later-line Chemotherapy
MASATSUNE SHIBUTANI, HISASHI NAGAHARA, TATSUNARI FUKUOKA, YASUHITO ISEKI, SHINJI MATSUTANI, EN WANG, KIYOSHI MAEDA, KOSEI HIRAKAWA and MASAICHI OHIRA

Anticancer Research February 2019, 39 (2) 1051-1057; DOI: https://doi.org/10.21873/anticanres.13212
You have access
Trastuzumab With S-1 Plus Cisplatin in HER2-positive Advanced Gastric Cancer Without Measurable Lesions: OGSG 1202
SHUNJI ENDO, YUKINORI KUROKAWA, MAKIO GAMOH, YUTAKA KIMURA, JIN MATSUYAMA, HIROKAZU TANIGUCHI, ATSUSHI TAKENO, RYOHEI KAWABATA, JUNJI KAWADA, TORU MASUZAWA, KAZUYOSHI YAMAMOTO, KOUJI KOBAYASHI, DAISUKE SAKAI, TOSHIO SHIMOKAWA and TAROH SATOH

Anticancer Research February 2019, 39 (2) 1059-1065; DOI: https://doi.org/10.21873/anticanres.13213
You have access
Clinical Outcomes of 42 Renal Cell Carcinoma Patients With Metastases Solely to the Lung Who Received Sorafenib as Second-line Systemic Therapy
HIDEAKI MIYAKE, YUTO MATSUSHITA, HIROMITSU WATANABE, KEITA TAMURA, DAISUKE MOTOYAMA, TOSHIKI ITO, TAKAYUKI SUGIYAMA and ATSUSHI OTSUKA

Anticancer Research February 2019, 39 (2) 1067-1072; DOI: https://doi.org/10.21873/anticanres.13214
You have access
Influence of Postoperative Surgical Complications After Gastrectomy on Body Weight and Body Composition Changes in Patients With Gastric Cancer
TORU AOYAMA, TAKAKI YOSHIKAWA, YUKIO MAEZAWA, KENKI SEGAMI, KAZUKI KANO, MASAKATSU NUMATA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, HIROHITO FUJIKAWA, KEISUKE KOMORI, TSUTOMU HAYASHI, TSUTOMU SATO, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, TAKASHI OGATA, HARUHIKO CHO and TAKASHI OSHIMA

Anticancer Research February 2019, 39 (2) 1073-1078; DOI: https://doi.org/10.21873/anticanres.13215
You have access
Serum CA 19.9 Levels in Patients With Benign and Malignant Disease: Correlation With the Serum Protein Electrophoretic Pattern
SIMON GUNDÍN-MENÉNDEZ, VICTOR MOLINA SANTOS, MARINA PARRA-ROBERT, XAVIER FILELLA PLA, JOSEP M. AUGE FRADERA and RAFAEL MOLINA PORTO

Anticancer Research February 2019, 39 (2) 1079-1083; DOI: https://doi.org/10.21873/anticanres.13216
You have access
Combination of Serum Albumin and Cholinesterase Levels as Prognostic Indicator in Patients ith Colorectal Cancer
MANABU YAMAMOTO, HIROAKI SAITO, CHIHIRO UEJIMA, AKIMITSU TANIO, YOICHIRO TADA, TOMOYUKI MATSUNAGA, TERUHISA SAKAMOTO, SOICHIRO HONJO, KEIGO ASHIDA and YOSHIYUKI FUJIWARA

Anticancer Research February 2019, 39 (2) 1085-1090; DOI: https://doi.org/10.21873/anticanres.13217

Main menu

User menu

Search

Table of Contents

Reviews

Experimental Studies

Clinical Studies

In this issue

Jump to